These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32984220)

  • 1. Thrombin Generation in Preterm Newborns With Intestinal Failure-Associated Liver Disease.
    Ghirardello S; Raffaeli G; Scalambrino E; Cortesi V; Roggero P; Peyvandi F; Mosca F; Tripodi A
    Front Pediatr; 2020; 8():510. PubMed ID: 32984220
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.
    Lauriti G; Zani A; Aufieri R; Cananzi M; Chiesa PL; Eaton S; Pierro A
    JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):70-85. PubMed ID: 23894170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procoagulant imbalance in preterm neonates detected by thrombin generation procedures.
    Tripodi A; Raffaeli G; Scalambrino E; Padovan L; Clerici M; Chantarangkul V; Cavallaro G; Peyvandi F; Mosca F; Ghirardello S
    Thromb Res; 2020 Jan; 185():96-101. PubMed ID: 31786478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants.
    Clauss C; Tack V; Macchiarulo M; Akerman M; El-Chaar G; Hanna N; Tiozzo C
    Front Pediatr; 2022; 10():900068. PubMed ID: 35989991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish Oil Monotherapy for Intestinal Failure-Associated Liver Disease on SMOFlipid in the Neonatal Intensive Care Unit.
    Lee S; Sung SI; Park HJ; Chang YS; Park WS; Seo JM
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33113902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
    Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.
    Bishay M; Pichler J; Horn V; Macdonald S; Ellmer M; Eaton S; Hill S; Pierro A
    J Pediatr Surg; 2012 Feb; 47(2):359-62. PubMed ID: 22325390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approximately 50% of acute intestinal failure (AIF) patients on short-term parenteral nutrition (PN) have intestinal failure-associated liver disease (IFALD) without effect on hospital length of stay and mortality.
    Cheang LY; Chong NCJ; Poh BY; Tan LB; Goh JLR; Lee MS; Tan KCT; Kadir HA; Cheah CCM; Salazar E
    Clin Nutr ESPEN; 2024 Jun; 61():140-144. PubMed ID: 38777425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative Enteral Nutrition Guidelines Reduce the Risk of Intestinal Failure-Associated Liver Disease in Surgical Infants.
    Shores DR; Alaish SM; Aucott SW; Bullard JE; Haney C; Tymann H; Nonyane BAS; Schwarz KB
    J Pediatr; 2018 Apr; 195():140-147.e1. PubMed ID: 29402454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy.
    Lee S; Park HJ; Yoon J; Hong SH; Oh CY; Lee SK; Seo JM
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):437-40. PubMed ID: 25560679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of serum fibroblast growth factor 19 and liver stiffness for intestinal failure associated liver disease-cholestasis.
    Xiao Y; Maitiabula G; Wang H; Xu K; Zhang Y; Fu N; Zhang L; Gao T; Sun G; Song D; Gao X; Wang X
    Clin Nutr ESPEN; 2024 Feb; 59():89-95. PubMed ID: 38220411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors derived from parenteral nutrition associated with cholestasis in 612 neonates].
    Tang QY; Wang Y; Feng Y; Tao YX; Wu J; Cai W
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):838-42. PubMed ID: 18282416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation.
    Habib M; Roberts LN; Patel RK; Wendon J; Bernal W; Arya R
    Liver Int; 2014 May; 34(5):672-8. PubMed ID: 24164805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO2/NO3 plasma profile under different parenteral nutrition regimens in newborns.
    Dalgiç N; Hasanoğlu A; Tümer L; Koç E; Ergenekon E; Cinasal G; Bukan N
    Ann Nutr Metab; 2007; 51(1):22-6. PubMed ID: 17356262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.
    Fligor SC; Tsikis ST; Hirsch TI; Pan A; Moskowitzova K; Rincon-Cruz L; Whitlock AE; Mitchell PD; Nedder AP; Gura KM; Fraser DA; Puder M
    Gastroenterology; 2023 Sep; 165(3):733-745.e9. PubMed ID: 37263310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN.
    Lal S; Pironi L; Wanten G; Arends J; Bozzetti F; Cuerda C; Joly F; Kelly D; Staun M; Szczepanek K; Van Gossum A; Schneider SM;
    Clin Nutr; 2018 Dec; 37(6 Pt A):1794-1797. PubMed ID: 30017241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal failure-associated liver disease in hospitalised children.
    Pichler J; Horn V; Macdonald S; Hill S
    Arch Dis Child; 2012 Mar; 97(3):211-4. PubMed ID: 22247247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing the Progression of Intestinal Failure-Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid.
    Diamond IR; Grant RC; Pencharz PB; de Silva N; Feldman BM; Fitzgerald P; Sigalet D; Dicken B; Turner J; Marchand V; Ling SC; Moore AM; Avitzur Y; Wales PW
    JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):866-877. PubMed ID: 26838529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal failure-associated liver disease: what do we know today?
    Kelly DA
    Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.